SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-088662
Filing Date
2022-08-10
Accepted
2022-08-10 16:39:12
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 tm2222025-1_s3.htm S-3 470245
2 EXHIBIT 1.2 tm2222025d2_ex1-2.htm EX-1.2 207201
3 EXHIBIT 4.3 tm2222025d2_ex4-3.htm EX-4.3 388206
4 EXHIBIT 5.1 tm2222025d2_ex5-1.htm EX-5.1 28827
5 EXHIBIT 23.2 tm2222025d2_ex23-2.htm EX-23.2 2594
6 EX-FILING FEES tm2222025d2_ex-filingfees.htm EX-FILING FEES 30279
7 GRAPHIC tm2222025d2_ex5-1img001.jpg GRAPHIC 2186
8 GRAPHIC tm2222025d2_ex5-1img002.jpg GRAPHIC 1592
9 GRAPHIC lg_immuneering-4clr.jpg GRAPHIC 19102
  Complete submission text file 0001104659-22-088662.txt   1160275
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266738 | Film No.: 221152347
SIC: 2834 Pharmaceutical Preparations